ストックスクリーナーアプリを入手
3.44
4.18%
-0.15
Autonomix Medical Inc (AMIX) 最新ニュース
Autonomix Medical Inc (AMIX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Autonomix Medical Inc (AMIX) Institutional Confidence - TradingKey
Autonomix Medical Inc (AMIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AMIX|Autonomix Medical Inc|Price:2.920|Chg%:-0.580 - TradingKey
Autonomix Medical Inc (AMIX) Balance Sheet - TradingKey
AMIX|Autonomix Medical Inc|Price:2.755|Chg%:-0.165 - TradingKey
Autonomix Medical Inc. (AMIX) Plunges Over 16% – Key Support Levels Under PressureInvestment Factor - dars.gov.et
TradingKey - TradingKey
AMIX|Autonomix Medical Inc|Price:2.900|Chg%:-0.600 - TradingKey
AMIX Drops As Warrant Inducement Raises Dilution Fears - StocksToTrade
Autonomix Medical, Inc. (AMIX) stock price, news, quote and history - Yahoo Finance UK
Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study - marketscreener.com
Autonomix reports preclinical data on renal nerve sensing tech - Investing.com
Autonomix reports preclinical data on renal nerve sensing tech By Investing.com - Investing.com Canada
Autonomix Medical Reports Preclinical Study Shows Neural Sensing Platform Can Detect and Localize Renal Nerve Activity - Quiver Quantitative
In an animal study, Autonomix catheter detected kidney nerve changes - Stock Titan
Autonomix Medical, Inc. (AMIX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Autonomix Medical Secures New US Patent Strengthening Next-Generation Precision Neuromodulation Platform - TradingView
Autonomix Medical receives patent for nervous system assessment tech - Investing.com
New Autonomix patent covers nerve-signal monitoring during treatment - Stock Titan
Frontier tech research, news & data - MLQ.ai
Autonomix Medical (AMIX) Proxy filing Summary - Quartr
Autonomix Medical (AMIX) Registration filing Summary - Quartr
Autonomix Medical, Inc. Common Stock (NASDAQ: AMIX) Share Price, AMIX Stock News, AMIX Share Price & Updates - Kalkine
Autonomix Medical raises up to $2.6M through warrant inducement - MSN
Autonomix Medical (AMIX) Retreats to $5.02 as Support Level TestedFear Greed Index - dars.gov.et
Autonomix Medical (AMIX) Q2 2026 Earnings: Wider-Than-Expected Loss Highlights Cash Burn for Clinical-Stage Device FirmEarnings Risk Report - dars.gov.et
Autonomix Medical Announces $2.6 Million At-the-Market Warrant Inducement Agreement to Accelerate Growth - Minichart
Autonomix Medical Secures $2.6 Million From Warrant Inducement, Issues New Series D Warrants - TradingView
Autonomix granted U.S. patent for overactive bladder diagnosis - TipRanks
Autonomix Medical receives patent for overactive bladder device - Investing.com UK
Autonomix Medical receives patent for overactive bladder device By Investing.com - Investing.com Nigeria
Autonomix Medical Receives U.S. Patent Expanding Neural Sensing Platform Into Overactive Bladder Urology Market - Moomoo
Autonomix Medical Receives U.S. Patent Expanding Neural Sensing Platform into Overactive Bladder Urology Market - Quiver Quantitative
Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform - GlobeNewswire
Autonomix Patent Covers Catheter That Maps and Treats Bladder Nerves - Stock Titan
Investor Agrees to Exercise 428,731 Autonomix Warrants - Stock Titan
Autonomix enters into $2.6M warrant inducement priced at $6.00 - TipRanks
Autonomix Medical Enters into $2.6 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules - marketscreener.com
Autonomix Medical wins new patent for neural sensing technology - Proactive financial news
symbol__ Stock Quote Price and Forecast - CNN
Autonomix granted Canadian patent for neural sensing - TipRanks
Autonomix Medical Announces Canadian Patent Grant Strengthening Its Real-Time Nerve Sensing and Denervation IP Portfolio - Quiver Quantitative
Autonomix Medical Strengthens Global Intellectual Property Position with New Neural Sensing Patent Grant - GlobeNewswire
Autonomix Medical Inc. (AMIX) Slips 12.48% as Shares Test Key Support LevelsDealer Gamma - dars.gov.et
Autonomix Medical Regains Nasdaq Compliance, Preserving Listing Status - The Globe and Mail
Autonomix Medical, Inc. 8-K Filing: NASDAQ Compliance Update and Company Details (July 2026) - Minichart
Autonomix Medical regains Nasdaq compliance after 10-day $1.00 bid-price streak - TradingView
Autonomix Medical (NASDAQ: AMIX) restores Nasdaq minimum bid price compliance - Stock Titan
Autonomix Medical (AMIX) Slips 1.58% as Stock Tests Key Support ZoneElliott Wave Count - dars.gov.et
AMIX Q2 2026 Earnings: Loss Narrows as Clinical Progress Offsets Cautious OutlookROIC Trend Report - dars.gov.et
AMIXAutonomix Medical Inc Options - Finviz
Autonomix Medical (AMIX) Surges 13% as Bulls Test Key Resistance at $7.25Short Setup Alerts - dars.gov.et
Autonomix Medical Inc. (AMIX) Q1 2026 Earnings: Narrower-than-Expected Loss as Pre-Revenue Company Advances R&DBuyback Announcement Report - dars.gov.et
AMIX Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift Stock Amid Continued Pre-Revenue Stage - DonanımHaber
AMIX Q1 2026 Earnings: Narrower Loss Surprise Fails to Lift Shares as Pre-Revenue Progress Remains in Focus - dars.gov.et
Enterprise value to EBIT forward of Autonomix Medical, Inc. – NASDAQ:AMIX - TradingView
Price to book forward of Autonomix Medical, Inc. – NASDAQ:AMIX - TradingView
Autonomix Medical Enacts 1-for-21 Reverse Stock Split - TipRanks
Autonomix Medical (AMIX) consolidates shares in 1-for-21 reverse stock split - Stock Titan
1.04%
11.95%
大文字化:
|
ボリューム (24 時間):